Literature DB >> 16455265

DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects.

Kyoung-Jin Ahn1, Hey Kyeong Jeong, Han-Saem Choi, Soo-Ryoon Ryoo, Yeon Ju Kim, Jun-Seo Goo, Se-Young Choi, Jung-Soo Han, Ilho Ha, Woo-Joo Song.   

Abstract

Among the various phenotypes seen in Down syndrome (DS), mental retardation is the most common and most debilitating condition suffered by individuals with DS. The DYRK1A gene on human chromosome 21q22.2 encodes a subfamily of protein kinases that displays dual substrate specificities and is known to play a critical role in neurodevelopment. To study DS mental retardation, we have generated transgenic mice that contain only one copy of the complete human DYRK1A gene in a bacterial artificial chromosome. The transgenic mice showed significant impairment in hippocampal-dependent memory tasks in a Morris water maze. Interestingly, we observed shifts in both long-term potentiation and long-term depression, which suggests a role for DYRK1A in bidirectional synaptic plasticity. These mice represent the most clinically relevant DYRK1A mouse model to date and provide us a valuable tool for the in vivo study of mechanisms that underlie the learning and memory deficit in DS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455265     DOI: 10.1016/j.nbd.2005.12.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  91 in total

1.  Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).

Authors:  Tatyana Adayev; Jerzy Wegiel; Yu-Wen Hwang
Journal:  Arch Biochem Biophys       Date:  2010-12-24       Impact factor: 4.013

Review 2.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

3.  Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

Authors:  Timothy M E Scales; Shen Lin; Michaela Kraus; Robert G Goold; Phillip R Gordon-Weeks
Journal:  J Cell Sci       Date:  2009-06-23       Impact factor: 5.285

4.  Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.

Authors:  Karol Dowjat; Tatyana Adayev; Wojciech Kaczmarski; Jerzy Wegiel; Yu-Wen Hwang
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

Review 5.  Down syndrome: the brain in trisomic mode.

Authors:  Mara Dierssen
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

6.  The E3 ligase APC/C-Cdh1 is required for associative fear memory and long-term potentiation in the amygdala of adult mice.

Authors:  Joseph E Pick; Marcos Malumbres; Eric Klann
Journal:  Learn Mem       Date:  2012-12-14       Impact factor: 2.460

7.  Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation.

Authors:  Siddhartha Mondragón-Rodríguez; Emilie Trillaud-Doppia; Anthony Dudilot; Catherine Bourgeois; Michel Lauzon; Nicole Leclerc; Jannic Boehm
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

8.  Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1).

Authors:  Luzhou Xing; Martha Salas; Hong Zhang; Julia Gittler; Thomas Ludwig; Chyuan-Sheng Lin; Vundavalli V Murty; Wayne Silverman; Ottavio Arancio; Benjamin Tycko
Journal:  Mamm Genome       Date:  2012-10-25       Impact factor: 2.957

9.  Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).

Authors:  Bryan T Mott; Cordelle Tanega; Min Shen; David J Maloney; Paul Shinn; William Leister; Juan J Marugan; James Inglese; Christopher P Austin; Tom Misteli; Douglas S Auld; Craig J Thomas
Journal:  Bioorg Med Chem Lett       Date:  2009-10-03       Impact factor: 2.823

10.  A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinases.

Authors:  Stéphane Peineau; Céline S Nicolas; Zuner A Bortolotto; Ratan V Bhat; W Jonathan Ryves; Adrian J Harwood; Pascal Dournaud; Stephen M Fitzjohn; Graham L Collingridge
Journal:  Mol Brain       Date:  2009-07-07       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.